The Law Library

Microbiology Devices - Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly with Clinical Specimens (Us Food and Drug Administration Regulation) (Fda) (2018 Edition) The Law Library

Microbiology Devices - Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly With Clinical Specimens (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Microbiology Devices - Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly With Clinical Specimens (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA) is reclassifying antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens that are currently regulated as influenza virus serological reagents from class I into class II with special controls and into a new device classification regulation. This book contains: - The complete text of the Microbiology Devices - Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly With Clinical Specimens (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section